Publications

Publication -

Adhikari, B., Schneider, K., Diebold, M., Sotriffer, C., & Wolf, E. (2024). Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA). eLife, 13, RP98450. https://doi.org/10.7554/eLife.98450

Publication -

Azeez, K. R. A., Saraswati, H., Mosler, T., Hanke, T., Ho-Xuan, H., Neder, N., Sivashanmugam, S. A., Heinz, M., Schwalm, M. P., Giuliani, G., Rathore, R., Kazi, R., Kumar, R., Mitrovic, M., Prieto-Garcia, C., Bailey, H. J., Mathea, S., Hummer, G., Đikić, I., Müller, S., … Knapp, S. (2026). Discovery and Development of a Potent LIMK2 Isoform-Specific Degrader. ACS chemical biology, 21(5), 1158–1176. https://doi.org/10.1021/acschembio.6c00137

Publication -

Berner, N., Bayer, F. P., George, A., Kabella, N., Bergamasco, F. L., & Kuster, B. (2026). Proteome-wide dose-response measurements for the characterization of drug mechanism of action. Targetome, 2(1), e001. https://doi.org/10.48130/targetome-0025-0011

Publication -

Bhandare, P., Narain, A., Hofstetter, J., Rummel, T., Wenzel, J., Schülein-Völk, C., Lamer, S., Eilers, U., Schlosser, A., Eilers, M., Erhard, F., & Wolf, E. (2024). Phenotypic screens identify SCAF1 as critical activator of RNAPII elongation and global transcription. Nucleic Acids Research, gkae1219. https://doi.org/10.1093/nar/gkae1219

Publication -

Cakmak, P., Lun, J. H., Singh, A., Macas, J., Schupp, J., Schuck, J., Mahmoud, Z., Kohler, M., Starzetz, T., Burger, M. C., Steidl, E., Hasse, L. M., Hattingen, E., Plate, K. H., Reiss, Y., & Imkeller, K. (2025). Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures. Immunity, 58(11), 2847-2863 e2848. https://doi.org/10.1016/j.immuni.2025.09.018

Publication -

Dehmer, M., Trunk, K., Gallant, P., Fleischhauer, D., Müller, M., Herold, S., Cossa, G., Conte, F., Koster, J., Sauer, F., Schülein-Völk, C., Ade, C. P., Vidal, R., Kisker, C., Versteeg, R., Beli, P., Vos, S. M., Eilers, M., & Büchel, G. (2025). The USP11/TCEAL1 complex promotes transcription elongation to sustain oncogenic gene expression in neuroblastoma. Genes & Development. https://doi.org/10.1101/gad.352166.124

Publication -

Gotthardt, G., Weckesser, J., Tascher, G., Da Gama, S. B., Uckelmann, H. J., Schwalm, M., Mosler, T., Ferrario, G., Münch, C., Knapp, S., & Müller, S. (2024). The cysteine-reactive covalent RNF4 ligand CCW16 induces ferroptosis in AML cells by activation of ROS signaling. bioRxiv. https://doi.org/10.1101/2024.12.12.628083

Publication -

Gotthardt, G., Keiten-Schmitz, J., & Müller, S. (2025). Reprogramming SUMO-primed ubiquitylation: opportunities in oncology and neurology. Trends in pharmacological sciences, 46(11), 1117–1129. https://doi.org/10.1016/j.tips.2025.09.002

Publication -

Gotthardt, G., Weckesser, J., Tascher, G., Barros da Gama, S., Uckelmann, H. J., Sun, S., Schwalm, M. P., Mosler, T., Ferrario, G., Friedmann Angeli, J. P., Münch, C., Knapp, S., & Müller, S. (2025). Cysteine-reactive covalent chloro-N-acetamide ligands induce ferroptosis mediated cell death. EMBO reports, 26(22), 5501–5532. https://doi.org/10.1038/s44319-025-00593-4

Publication -

Haag, A., Němec, V., Janovská, P., Bartošíková, J., Adhikari, B., Müller, J., Schwalm, M. P., Čada, Š., Ohmayer, U., Daub, H., Kim, Y., Born, F., Wolf, E., Bryja, V., & Knapp, S. (2025). Development and Discovery of a Selective Degrader of Casein Kinases 1 δ/ε. Journal of Medicinal Chemistry, 68(1), 506–530. https://doi.org/10.1021/acs.jmedchem.4c02201

Publication -

Han, S., Haertle, L., Munawar, U., Truger, M., Hainold, A. S., Lee, C. Y., Kurian, S., Verbruggen, C., Nerreter, S., Vogt, C., Besant, E., Rein, N., Lehmann, J., Köppel, M., Tamamushi, Y., Zhou, X., Steinbrunn, T., Haaf, T., Küster, B., Slaby, O., … Kortüm, K. M. (2026). Promoter hypomethylation drives ABCB1-mediated carfilzomib resistance in multiple myeloma. Clinical epigenetics, 18(1), 59. https://doi.org/10.1186/s13148-026-02115-y

Publication -

Hernandez-Olmos, V., Patzke, J. V., Stone, C. E., Nair, R. K., Weller, K., Sauer, F., Endres, E., Jamai, O., Rachor, L., Warmutz, C. H., Schwalm, M. P., Mitrovic, M., Grenier, V., Ehrler, J. H. M., Proschak, A., Heering, J., Sotriffer, C., Mulder, M. P. C., Knapp, S., Kisker, C., … Proschak, E. (2026). Structure Merging Approach Leads to New Dual Potent and Selective USP25/USP28 Inhibitors. Journal of medicinal chemistry, 69(9), 10140–10168. https://doi.org/10.1021/acs.jmedchem.5c03045

Publication -

Kabella, N., Bayer, F. P., Stamatiou, K., Abele, M., Sakhteman, A., Chang, Y. C., Wagner, V., Gabriel, A., Krumm, J., Reinecke, M., Holzner, M., Aigner, M., The, M., Hahne, H., Bassermann, F., Ludwig, C., Vagnarelli, P., & Kuster, B. (2025). Proteomic analyses identify targets, pathways, and cellular consequences of oncogenic KRAS signaling. Science signaling, 18(897), eadt6552. https://doi.org/10.1126/scisignal.adt6552

Publication -

Klink, N., Urban, S., Seier, J. A., Adhikari, B., Schwalm, M. P., Müller, J., Dorsch, M., Steinbach, P., Jung, J., Vogt, M., Kaschani, F., Koch, J., Führer, S., Kaiser, M., Schulze, N., Knapp, S., Wolf, E., Paschen, A., Grüner, B. M., & Gersch, M. (2026). Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors. Nature communications, 17(1), 4331. https://doi.org/10.1038/s41467-026-72295-x

Publication -

Kolak, A., Tschuck, J., Weiß, S. A. I., Kaemena, D., Klimm, K., Galhoz, A., Ringelstetter, L., Fennell, M., Merl-Pham, J., Artati, A., Strasser, S., Garippa, R., Witting, M., Zischka, H., Schick, J. A., Hauck, S. M., Menden, M. P., Vincendeau, M., Stockwell, B. R., & Hadian, K. (2026). MiR-940 Suppresses Ferroptosis by Controlling Expression of Key Regulatory Genes. Advanced science (Weinheim, Baden-Wurttemberg, Germany), e75830. Advance online publication. https://doi.org/10.1002/advs.75830

Publication -

Lee, C. Y., Han, S., Haertle, L., Munawar, U., Vogt, C., Streubel, J., Besse, A., Besse, L., Driessen, C., Einsele, H., Waldschmidt, J., Kortüm, M., & Kuster, B. (2026). Proteome profiling reveals NQO2 activity contributing to proteasome inhibitor resistance in multiple myeloma cell lines. Molecular & cellular proteomics : MCP, 101615. Advance online publication. https://doi.org/10.1016/j.mcpro.2026.101615

Publication -

Lenz, C., Elson, L., Dopfer, J., Farges, F., Krämer, A., Löhr, F., Müller, S., Guéret, S. M., Waldmann, H., Dötsch, V., Saxena, K., & Knapp, S. (2026). Overcoming Ligand Discovery Challenges: Developing Peptide-Based Tracers for SPSB2. ACS chemical biology, 21(2), 274–283. https://doi.org/10.1021/acschembio.5c00702

Publication -

Miletić, N., Weckesser, J., Mosler, T., Rathore, R., Hoffmann, M. E., Gehrtz, P., Schlesiger, S., Hartung, I. V., Berner, N., Wilhelm, S., Müller, J., Adhikari, B., Němec, V., Sivashanmugam, S. A., Elson, L., Holzmann, H., Schwalm, M. P., Hoffmann, L., Abdul Azeez, K. R., … Knapp, S. (2025). Workflow for E3 Ligase Ligand Validation for PROTAC Development. ACS Chemical Biology, 20(2), 507–521. https://doi.org/10.1021/acschembio.4c00812

Publication -

Mitrović, M., Greco, F. A., García, Y. C., Lučić, A., Hoffmann, L., Chander, R., Schönfeld, J., Liebisch, N., Sivashanmugam, S. A., Schwalm, M. P., Egner, M., Lewandowski, M., Merk, D., Morasch, V., Wolf, E., Müller, S., Hanke, T., Proschak, E., Hiesinger, K., & Knapp, S. (2026). Click. Screen. Degrade. A Miniaturized D2B Workflow for Rapid PROTAC Discovery. Journal of medicinal chemistry, 69(3), 2599–2624. https://doi.org/10.1021/acs.jmedchem.5c02543

Publication -

Müller, J., Daunke, T., Berner, N., Bhandare, P., Gebhardt, A., Hoffmann, L., Diebold, M., Vogt, M., Hofstetter, J., Cruz-Garcia, Y., Dudvarski-Stankovic, N., Schneider, K., Adhikari, B., Lamer, S., Schlosser, A., Büchel, G., Sos, M. L., Küster, B., Knapp, S., Wilhelm, S., … Wolf, E. (2026). AURORA A interacts with DICER and SETD2 to promote S-phase progression. EMBO reports, 10.1038/s44319-026-00850-0. Advance online publication. https://doi.org/10.1038/s44319-026-00850-0

Publication -

Munawar, U., Thurner, J., Nerreter, S., Nerreter, T., Leipold, A. M., Han, S., Verbruggen, C., Gerhard-Hartmann, E., Vogt, C., Grams, B., Kurian, S., Besant, E., Roth, S., Weingart, J., Eiring, P., Truger, M., Afrin, N., Steinbrunn, T., Tamamushi, Y., Zhou, X., … Kortüm, K. M. (2026). Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy. Leukemia, 40(6), 1227–1239. https://doi.org/10.1038/s41375-026-02920-7

Publication -

Park, M., Gonçalves, J. P. L., Deiser, S., Fenzl, S., Böhm, F. A., Steiger, K., Kossatz, S., Strittmatter, N., & Casini, A. (2026). A photocleavable peptidic Ru(ii) mass-tag enabling targeted DESI and MALDI mass spectrometry imaging in cancer tissues. Chemical science, 17(21), 10504–10510. https://doi.org/10.1039/d6sc00953k

Publication -

Raschke, P., Notova, S., Gatterdam, V., Frutiger, A., & Brunschweiger, A. (2026). Investigations into linker effects of DNA-VHL ligand conjugates by multiplexed affinity measurements using focal molography. RSC chemical biology, 7(5), 870–879. https://doi.org/10.1039/d6cb00011h

Publication -

Reissland, M., Hartmann, O., Tauch, S., Bugter, J. M., Prieto-Garcia, C., Schulte, C., Loebbert, S., Solvie, D., Bitman-Lotan, E., Narain, A., Jacomin, A.-C., Schuelein-Voelk, C., Fuss, C. T., Pahor, N., Ade, C., Buck, V., Potente, M., Li, V., Beliu, G., … Diefenbacher, M. E. (2024). USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer. Oncogene, 43(50), 3645–3659. https://doi.org/10.1038/s41388-024-03141-x

Publication -

Rieger, L., Irlinger, K., Füchsl, F., Tietje, M., Purcarea, A., Barbian, N., Faber, M., Vogelsang, C., Pfeuffer, L., Stotz, S., Karpiuk, O.,  Schulze, T, Augsburger, A., Glaisner, N., Konetzki, V., Friedel, S., Besse, A., Besse, L., Driessen, C., Buchner, M., Schwamborn, K., Steiger, K., Giansanti, P., Theurich, S., Waldschmidt, J., Kortüm, K.M., Hudecek, M., Einsele, H., Högner, M., Küster, B., Krackhardt, A. M., Hecker, J. S., Bassermann, F. (2026). Boosting CAR T-cell efficacy by blocking proteasomal degradation of membrane antigens. Blood, 147(5), 534–546. https://doi.org/10.1182/blood.2024027616

Publication -

Ringelstetter, L., Mersdorf-Weber, E., Schorpp, K., & Hadian, K. (2026). A non-canonical function of RNF8 opposes TRAF6-mediated stabilization of HIF1α. RSC chemical biology, 10.1039/d5cb00209e. Advance online publication. https://doi.org/10.1039/d5cb00209e

Publication -

Park, M., Rumpf, M., Moreno-Alcántar, G., Seiler, M., Zborovsky, L., Steiger, K., Kossatz, S., Casini, A., & Strittmatter, N. (2025). A Small Molecule Drug-Based Ru(II) Polypyridine Mass-Tag for Multimodal Imaging of Tissue Samples. ACS central science, 11(11), 2230–2239. https://doi.org/10.1021/acscentsci.5c01381

Publication -

Sflakidou, E., Adhikari, B., Siokatas, C., Wolf, E., & Sarli, V. (2024). Development of 2-Aminoadenine-Based Proteolysis-Targeting Chimeras (PROTACs) as Novel Potent Degraders of Monopolar Spindle 1 and Aurora Kinases. ACS Pharmacology & Translational Science, 7(11), 3488–3501. https://doi.org/10.1021/acsptsci.4c00405

Publication -

Skafar, V., de Souza, I., Ghosh, B., Ferreira Dos Santos, A., Porto Freitas, F., Chen, Z., Sun, S., Donate Castillo, M., Nepachalovich, P., Seufert, L., Bothe, S., Tschuck, J., Mathur, A., Nunes-Alves, A., Buhr, J., Aponte-Santamaría, C., Schmitz, W., Mack, M., Eilers, M., Bargou, R., … Friedmann Angeli, J. P. (2026). Riboflavin metabolism shapes FSP1-driven ferroptosis resistance. Nature cell biology, 28(4), 696–706. https://doi.org/10.1038/s41556-025-01856-x

Publication -

Soliman, N., Nedelko, T., Mandracci, G., Enssle, S., Grass, V., Fischer, J. C., Bassermann, F., Poeck, H., Kobold, S., El Khawanky, N., & Heidegger, S. (2025). Targeting Intracellular Innate RNA-Sensing Systems Overcomes Resistance to CAR T Cell Therapy in Solid Tumors. Cancer Research. https://doi.org/10.1158/0008-5472.CAN-24-3425

Publication -

Thielen, S. (2024). Forschungsdatenmanagement mit dem TUM-Data-Steward-Modell für den Sonderforschungsbereich UbiQancer. Bibliotheksforum Bayern, 18(4), 13-15. https://www.bibliotheksforum-bayern.de/fileadmin/archiv/2024-4/BFB_4_24_WEB_Meta.pdf

Publication -

Thomas, S. R., Iellici, T., Park, M., Klaus, E., Bileck, A., Gerner, C., Meier-Menches, S. M., & Casini, A. (2026). A Gold-PROTAC Degrades the Oncogenic Tyrosine Kinase MERTK: Insights into the Degradome from a Steady-State System. ACS chemical biology, 21(1), 170–186. https://doi.org/10.1021/acschembio.5c00860

Publication -

Tschuck, J., Skafar, V., Friedmann Angeli, J. P., & Hadian, K. (2025). The metabolic code of ferroptosis: Nutritional regulators of cell death. Trends in Biochemical Sciences, S0968000425001045. https://doi.org/10.1016/j.tibs.2025.04.007

Publication -

Wagner, K., Keiten-Schmitz, J., Adhikari, B., Patra, U., Husnjak, K., McNicoll, F., Dormann, D., Müller-McNicoll, M., Tascher, G., Wolf, E., & Müller, S. (2025). Induced proximity to PML protects TDP-43 from aggregation via SUMO–ubiquitin networks. Nature Chemical Biology. https://doi.org/10.1038/s41589-025-01886-4

Publication -

Weckesser, J., Miletić, N., Sivashanmugam, S. A., Ohmayer, U., Steger, M., Shashikadze, B., Gehrtz, P., Unzue Lopez, A., Wegener, A., Dietz, T. Y., Hammann, T., Hartung, I. V., Elson, L., Němec, V., Schwalm, M. P., Adhikari, B., Wolf, E., Krämer, A., Müller, S., Daub, H., … Knapp, S. (2026). On the Scope of DCAF1-Recruiting PROTACs Degrading Protein Kinases. Journal of medicinal chemistry, 10.1021/acs.jmedchem.6c00383. Advance online publication. https://doi.org/10.1021/acs.jmedchem.6c00383

Publication -

Zhang, C., Blanco, C. O., Khimich, A., Fogg, D. E., & Brunschweiger, A. (2026). On-oligonucleotide olefin metathesis in water. Nature communications, 10.1038/s41467-026-72995-4. Advance online publication. https://doi.org/10.1038/s41467-026-72995-4